Enhancing RPE Metabolism to Protect Cone Vision in Retinitis Pigmentosa
Boosting RPE Metabolic Support Offers a Promising Gene-Independent Strategy for RP Treatment A Striatech .pdf Case Study Retinitis Pigmentosa (RP)
Read moreBoosting RPE Metabolic Support Offers a Promising Gene-Independent Strategy for RP Treatment A Striatech .pdf Case Study Retinitis Pigmentosa (RP)
Read moreA recent study from Constance Cepko’s group at Harvard Medical School offers an encouraging advance toward therapeutic strategies for Retinitis
Read moreThe Advanced Microfluidic Platform Bridging the Gap Between Traditional Cell Culture and Human Physiology An IVTech Brochure & Case Study
Read moreAerska, a newly formed biotechnology company focused on transforming the treatment of neurological diseases, has officially launched with $21 million
Read moreA recent study by Janos Groh and colleagues in Mikael Simons’ group at the Institute of Neuronal Cell Biology, Technical
Read moreCantargia AB has announced a landmark agreement with Japanese pharma giant Otsuka Pharmaceutical Co., Ltd., granting Otsuka exclusive global rights
Read moreRetinal degeneration represents a primary cause of irreversible blindness, with both its onset and severity differing significantly among various conditions.
Read moreStriatech, a leader in preclinical vision research devices and tools, has unveiled its New Non-Aversive Animal Platform for the OptoDrum
Read moreThe unique OptoDrum device for automated in vivo assessment of visual performance in mice and rats offers unmatched capabilities for
Read moreA groundbreaking study by Groh et al., recently featured in Nature Communications, delves into the interplay between adaptive immunity and
Read more